CD20-targeted measles virus shows high oncolytic specificity in clinical samples from lymphoma patients independent of prior rituximab therapy

K. C. Yaiw, T. S. Miest, M. Frenzke, M. Timm, P. B. Johnston, R. Cattaneo

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'CD20-targeted measles virus shows high oncolytic specificity in clinical samples from lymphoma patients independent of prior rituximab therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences